Us Med, Llc Durable Medical Equipment & Medical Supplies Location: 99 Derby St 2nd Floor, Hingham, Massachusetts 02043 Phone: (781) 556-1086 |
Lincare Inc Durable Medical Equipment & Medical Supplies Location: 4 Keith Way, Hingham, Massachusetts 02043 Phone: (781) 749-7773 |
Cvs Pharmacy #48265 Durable Medical Equipment & Medical Supplies Location: 203 Linden Ponds Way, Hingham, Massachusetts 02043 Phone: (781) 534-7270 |
Cvs Pharmacy #01189 Durable Medical Equipment & Medical Supplies Location: 405 Lincoln Street, Hingham, Massachusetts 02043 Phone: (781) 749-1163 |
Cvs Pharmacy #01953 Durable Medical Equipment & Medical Supplies Location: 86 South St, Hingham, Massachusetts 02043 Phone: (781) 740-8952 |
Walgreens #19543 Durable Medical Equipment & Medical Supplies Location: 184 Lincoln St, Hingham, Massachusetts 02043 Phone: (781) 749-0487 |
Stop & Shop Pharmacy #35 Durable Medical Equipment & Medical Supplies Location: 400 Lincoln St, Hingham, Massachusetts 02043 Phone: (781) 749-5856 |
Adapthealth New England Llc Durable Medical Equipment & Medical Supplies Location: 37 Derby St, Hingham, Massachusetts 02043 Phone: (508) 206-9253 |
News Archive
Recommendations to reduce federal health care spending in a socially and fiscally responsible manner today were made in a letter to the Congressional Joint Committee on Deficit Reduction from the American College of Physicians.
Orexo AB (STO:ORX) today confirms that its partner, ProStrakan Group plc (LSE: PSK), has announced that the New Drug Application (NDA) filing for Abstral has been accepted for review by the US Food and Drug Administration (FDA).
For the second year in a row and third time in five years, Humana Inc. ranks #1 in overall performance - making it the easiest payer for health care providers to do business with - in a review of 2009 claims-payment data conducted by athenahealth Inc., a provider of Internet-based business services to doctors, and Physician's Practice magazine.
In the last five years, the landscape of type 2 diabetes treatment has changed dramatically. Two new classes of drugs - SGLT2 inhibitors and GLP-1 receptor agonists - have been shown to prevent some of the most serious diabetes complications, including heart and kidney conditions, in patients.
Synthon has announced that its subsidiary Synthon Pharmaceuticals, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for tadalafil tablets, 20 mg on April 13, 2012. Synthon's product is a generic and bioequivalent version of Eli Lilly & Co and United Therapeutics' Adcirca® tablets, which are indicated for the treatment of pulmonary arterial hypertension to improve exercise ability.
› Verified 3 days ago